Skip to content
The Policy VaultThe Policy Vault

tobramycin inhalation solutionMedica

Bronchiectasis, Non-Cystic Fibrosis

Initial criteria

  • age ≥ 18 years
  • Patient has Pseudomonas aeruginosa in culture of the airway (e.g., sputum culture, oropharyngeal culture, bronchoalveolar lavage culture)
  • Medication is prescribed by or in consultation with a pulmonologist

Approval duration

1 year